Faculty Opinions recommendation of An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955170.793461800 ◽

2012 ◽

Author(s):

John Kamholz

Keyword(s):

Neuropathic Pain ◽

Efficacy Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Download Full-text

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

Pain ◽

10.1016/j.pain.2012.06.024 ◽

2012 ◽

Vol 153 (10) ◽

pp. 2073-2082 ◽

Author(s):

Cory Toth ◽

Shefina Mawani ◽

Shauna Brady ◽

Cynthia Chan ◽

CaiXia Liu ◽

...

Keyword(s):

Neuropathic Pain ◽

Efficacy Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Download Full-text

A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.s38.003 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. S38.003-S38.003

Author(s):

C. Toth ◽

S. Mawani ◽

S. Brady ◽

C. Chan ◽

C. Liu ◽

...

Keyword(s):

Neuropathic Pain ◽

Efficacy Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Withdrawal Design ◽

Download Full-text

Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.02.007 ◽

2011 ◽

Vol 33 (2) ◽

pp. 159-166 ◽

Author(s):

Yuzhou Guan ◽

Xinsheng Ding ◽

Yan Cheng ◽

Dongsheng Fan ◽

Lan Tan ◽

...

Keyword(s):

Neuropathic Pain ◽

Controlled Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104054.560029 ◽

2008 ◽

Author(s):

Stephen Tyrer

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Download Full-text

Duloxetine for the Management of Diabetic Peripheral Neuropathic Pain: Evidence-Based Findings from Post Hoc Analysis of Three Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Studies

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.12.002 ◽

2007 ◽

Vol 29 (11) ◽

pp. 2536-2546 ◽

Author(s):

Daniel K. Kajdasz ◽

Smriti Iyengar ◽

Durisala Desaiah ◽

Misha-Miroslav Backonja ◽

John T. Farrar ◽

...

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Download Full-text

A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

Pain ◽

10.1097/j.pain.0000000000000263 ◽

2015 ◽

Vol 156 (10) ◽

pp. 2013-2020 ◽

Author(s):

Dan Ziegler ◽

W. Rachel Duan ◽

Guohua An ◽

James W. Thomas ◽

Wolfram Nothaft

Keyword(s):

Neuropathic Pain ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo

Download Full-text

Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients

Journal of Diabetes Investigation ◽

10.1111/jdi.13013 ◽

2019 ◽

Vol 10 (5) ◽

pp. 1299-1306 ◽

Author(s):

Masayuki Baba ◽

Norimitsu Matsui ◽

Masanori Kuroha ◽

Yosuke Wasaki ◽

Shoichi Ohwada

Keyword(s):

Neuropathic Pain ◽

Phase Iii ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Asian Patients ◽

Phase Iii Study

Download Full-text

The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials

Expert Opinion on Drug Safety ◽

10.1080/14740338.2020.1764934 ◽

2020 ◽

Vol 19 (6) ◽

pp. 707-733 ◽

Author(s):

Marie Selvy ◽

Mélissa Cuménal ◽

Nicolas Kerckhove ◽

Christine Courteix ◽

Jérôme Busserolles ◽

...

Keyword(s):

Clinical Trials ◽

Neuropathic Pain ◽

Randomized Clinical Trials ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo

Download Full-text

The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study

Pain ◽

10.1016/j.pain.2014.08.014 ◽

2014 ◽

Vol 155 (11) ◽

pp. 2263-2273 ◽

Author(s):

Dyveke T. Demant ◽

Karen Lund ◽

Jan Vollert ◽

Christoph Maier ◽

Märtha Segerdahl ◽

...

Keyword(s):

Neuropathic Pain ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo

Download Full-text

Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(16)00017-x ◽

2016 ◽

Vol 15 (6) ◽

pp. 555-565 ◽

Author(s):

Nadine Attal ◽

Daniel C de Andrade ◽

Frédéric Adam ◽

Danièle Ranoux ◽

Manoel J Teixeira ◽

...

Keyword(s):

Neuropathic Pain ◽

Botulinum Toxin ◽

Botulinum Toxin A ◽

Controlled Trial ◽

Toxin A ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text